By analyzing plasma samples from healthy donors and breast cancer patients, we identified epidermal growth factor receptor 2 (HER2) and epithelial cellular adhesion molecule (EpCAM) as exosomal biomarkers for detecting HER2-positive breast cancer. This evidence concerns the gene EPCAM and breast carcinoma.